Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Agents which regulate, inhibit, or modulate the activity and/or expression of connective tissue growth factor (CTGF) as a unique means to both lower intraocular pressure and treat glaucomatous retinopathies/optic neuropathies

US Patent 7351407 · Granted Apr 1, 2008

Estimated economic value: $81,769,000

Assignee

Inventors

View full patent text on Google Patents →